Literature DB >> 9971784

Identification of protein instability determinants in the carboxy-terminal region of c-Myb removed as a result of retroviral integration in murine monocytic leukemias.

J Bies1, V Nazarov, L Wolff.   

Abstract

The c-myb oncogene has been a target of retroviral insertional mutagenesis in murine monocytic leukemias. One mechanism by which c-myb can be activated is through the integration of a retroviral provirus into the central portion of the locus, causing premature termination of c-myb transcription and translation. We had previously shown that a leukemia-specific c-Myb protein, truncated at the site of proviral integration by 248 amino acids, had approximately a fourfold-increased half-life compared to the normal c-Myb protein, due to its ability to escape rapid degradation by the ubiquitin-26S proteasome pathway. Here we provide evidence for the existence of more than one instability determinant in the carboxy-terminal region of the wild-type protein, which appear to act independently of each other. The data were derived from examination of premature termination mutants and deletion mutants of the normal protein, as well as analysis of another carboxy-terminally truncated protein expressed in leukemia. Evidence is provided that one instability determinant is located in the terminal 87 amino acids of the protein and another is located in the vicinity of the internal region that has leucine zipper homology. In leukemias, different degrees of protein stability are attained following proviral integration depending upon how many determinants are removed. Interestingly, although PEST sequences (rich in proline, glutamine, serine, and threonine), often associated with degradation, are found in c-Myb, deletion of PEST-containing regions had no effect on protein turnover. This study provides further insight into how inappropriate expression of c-Myb may contribute to leukemogenesis. In addition, it will facilitate further studies aimed at characterizing the specific role of individual regions of the normal protein in targeting to the 26S proteasome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9971784      PMCID: PMC104446     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Moloney murine leukemia virus-induced myeloid tumors in adult BALB/c mice: requirement of c-myb activation but lack of v-abl involvement.

Authors:  G L Shen-Ong; L Wolff
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Deregulated c-myb disrupts interleukin-6- or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: role in leukemogenesis.

Authors:  M Selvakumaran; D A Liebermann; B Hoffman-Liebermann
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

3.  Acute myeloid leukemia induction by amphotropic murine retrovirus (4070A): clonal integrations involve c-myb in some but not all leukemias.

Authors:  L Wolff; R Koller; W Davidson
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

4.  c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock.

Authors:  B Lüscher; R N Eisenman
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

5.  Nucleotide sequence of the envelope gene of Friend murine leukemia virus.

Authors:  W Koch; G Hunsmann; R Friedrich
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

6.  Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure.

Authors:  C Kanei-Ishii; E M MacMillan; T Nomura; A Sarai; R G Ramsay; S Aimoto; S Ishii; T J Gonda
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

7.  Murine myb protooncogene mRNA: cDNA sequence and evidence for 5' heterogeneity.

Authors:  T P Bender; W M Kuehl
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

8.  New sites of proviral integration associated with murine promonocytic leukemias and evidence for alternate modes of c-myb activation.

Authors:  R Mukhopadhyaya; L Wolff
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

9.  Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain.

Authors:  Y L Hu; R G Ramsay; C Kanei-Ishii; S Ishii; T J Gonda
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

10.  Targeted degradation of c-Fos, but not v-Fos, by a phosphorylation-dependent signal on c-Jun.

Authors:  A G Papavassiliou; M Treier; C Chavrier; D Bohmann
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

View more
  10 in total

1.  Myeloid-specific inactivation of p15Ink4b results in monocytosis and predisposition to myeloid leukemia.

Authors:  Juraj Bies; Marek Sramko; Joanna Fares; Michael Rosu-Myles; Steven Zhang; Richard Koller; Linda Wolff
Journal:  Blood       Date:  2010-05-10       Impact factor: 22.113

2.  Stress-induced phosphorylation of Thr486 in c-Myb by p38 mitogen-activated protein kinases attenuates conjugation of SUMO-2/3.

Authors:  Juraj Bies; Marek Sramko; Linda Wolff
Journal:  J Biol Chem       Date:  2013-11-20       Impact factor: 5.157

3.  Functional analysis of carboxy-terminal deletion mutants of c-Myb.

Authors:  D M Wang; J W Dubendorff; C H Woo; J S Lipsick
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

4.  Use of recombinant cell-permeable small peptides to modulate glucocorticoid sensitivity of acute lymphoblastic leukemia cells.

Authors:  Chuan-dong Geng; Wayne V Vedeckis
Journal:  Biochemistry       Date:  2010-10-19       Impact factor: 3.162

5.  Human T-cell lymphotropic virus type 1 Tax represses c-Myb-dependent transcription through activation of the NF-kappaB pathway and modulation of coactivator usage.

Authors:  C Nicot; R Mahieux; C Pise-Masison; J Brady; A Gessain; S Yamaoka; G Franchini
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

6.  Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells.

Authors:  Feng Fang; Michael A Rycyzyn; Charles V Clevenger
Journal:  Endocrinology       Date:  2008-11-26       Impact factor: 4.736

Review 7.  Myb proteins: angels and demons in normal and transformed cells.

Authors:  Ye Zhou; Scott A Ness
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

8.  c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis.

Authors:  Lucia Knopfová; Petr Beneš; Lucie Pekarčíková; Markéta Hermanová; Michal Masařík; Zuzana Pernicová; Karel Souček; Jan Smarda
Journal:  Mol Cancer       Date:  2012-03-23       Impact factor: 27.401

9.  GSK3 regulates the expressions of human and mouse c-Myb via different mechanisms.

Authors:  Kyoko Kitagawa; Yojiro Kotake; Yoshihiro Hiramatsu; Ning Liu; Sayuri Suzuki; Satoki Nakamura; Akira Kikuchi; Masatoshi Kitagawa
Journal:  Cell Div       Date:  2010-11-21       Impact factor: 5.130

10.  Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis.

Authors:  S E Salghetti; M Muratani; H Wijnen; B Futcher; W P Tansey
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.